Research
Learn about published research as well as leading-edge basic and translational research initiatives from St. Jude laboratories.
SMARCB1: Genetic ‘canary in a coal mine’ sparks research
Scientist spent more than a decade finding out how this genetic mutation causes different cancers.
Childhood Solid Tumor Network moves to the cloud with additional data and analytic tools
Scientists interested in studying pediatric solid tumors now have this comprehensive, interactive online shop for patient-derived tumor information.
Unraveling the ambiguity of risk for childhood cancer survivors
Clinical specialists are learning this about the future for childhood cancer survivors and how to help them.
Staff scientists in core research facilities accelerate and broaden biomedical discovery
These labs are highly specialized and deliver researchers access to advanced and speedy scientific results.
CHANGE-seq: a novel, simple and scalable method to understand genome editors
Making DNA into a circle, called molecular circularization, has revealed a whole new way to look at genome editing.
Searching for the next pandemic flu virus? There’s another factor to keep in mind.
Researchers find the stability of this protein is key to the pandemic potential of swine flu.
TP53: One important gene in rare cancers - an update
St. Jude clinicians and researchers seek answers to some of the rarest pediatric tumors and diseases, including adrenocortical tumors. Read more about their work uncovering the TP53 gene.
Cloud redesign offers enhanced user experience
Read how this redesign offers computational scientists an edge when it comes to genomics and other omics.
Collaborating on SARS-CoV-2 and pediatric cancer
This collaboration on infection prevention pivoted early in the SARS-CoV-2 pandemic and did this global pediatric cancer community.
A vaccine to prevent ear infections? Here’s the latest.
Almost everyone gets ear infections. This vaccine may change that.